Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/065691external-prioritypatent/WO2013075035A1/en
Application filed by Alnylam Pharmaceuticals IncfiledCriticalAlnylam Pharmaceuticals Inc
Publication of TN2014000211A1publicationCriticalpatent/TN2014000211A1/en
The present invention provides RNAi agents, e.g., double stranded RNAi agents, that target the transthyretin (TTR) gene and methods of using such RNAi agents for treating or preventing TTR- associated diseases.
TNP2014000211A2012-08-062014-05-14Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases
TN2014000211A1
(en)